Search

Ian Paul Shadforth

age ~46

from Cary, NC

Also known as:
  • Ian P Shadforth
  • Ian C Shadforth
  • Ian H

Ian Shadforth Phones & Addresses

  • Cary, NC
  • Petaluma, CA
  • Durham, NC
  • Alameda, CA
  • San Francisco, CA

Work

  • Company:
    Alere (formerly inverness medical)
    Jun 2010
  • Position:
    Director of integrated health

Education

  • Degree:
    MBA
  • School / High School:
    The University of Dundee
    2006 to 2008
  • Specialities:
    Entrepreneurship

Skills

Strategic Direction and Planning • Systems Development • Cross Functional Management • Product Development • Informatics • Healthcare • Cross Functional Team Leadership • Strategic Planning • Innovation • Strategy • Medical Devices • Program Management • Start Ups • Mobile Devices • Lifesciences • Enterprise Software • Bioinformatics • Biotechnology • It Strategy • R&D • Leadership • Life Sciences • Research and Development

Awards

Enterprise fellowship - Royal society of edinburgh and the bbsrc • Emerging chemometrician - Royal society of chemistry

Industries

Medical Devices

Us Patents

  • Analyte Testing Method And Device For Diabetes Mangement

    view source
  • US Patent:
    20110077493, Mar 31, 2011
  • Filed:
    Jun 30, 2010
  • Appl. No.:
    12/826674
  • Inventors:
    Ian SHADFORTH - San Francisco CA, US
    David PRICE - Pleasanton CA, US
    Gretchen ANDERSON - Oakland CA, US
    Lorraine COMSTOCK - Saratoga CA, US
    Mary McEVOY - Belmont CA, US
    Douglas GRAHAM - Moray, GB
    Alexander STRACHAN - Moray, GB
    Alistair LONGMUIR - Forres, GB
    Robert CAVAYE - Penarth, GB
    Gillian TEFT - Maryburgh, GB
  • Assignee:
    LifeScan Scotland Ltd. - Inverness-Shire
  • International Classification:
    A61B 5/00
  • US Classification:
    600365
  • Abstract:
    Various embodiments are described and illustrated to calculate an insulin bolus, recommend such bolus, and provide reminder messages for performing an additional glucose test.
  • Analyte Testing Method And Device For Calculating Basal Insulin Therapy

    view source
  • US Patent:
    20100332142, Dec 30, 2010
  • Filed:
    Jun 30, 2010
  • Appl. No.:
    12/826670
  • Inventors:
    Ian SHADFORTH - San Francisco CA, US
    David PRICE - Pleasanton CA, US
    Zara SIEH - Pleasanto CA, US
    Brenda MONTGOMERY - Bellevue WA, US
    Eric BERGMAN - Menlo Park CA, US
  • Assignee:
    LifeScan,Inc. - Milpitas CA
  • International Classification:
    G06F 19/00
    A61B 5/00
  • US Classification:
    702 19, 600300
  • Abstract:
    Described herein are various methods to ensure safety and the compliance of therapeutic diabetes protocols. The method can be achieved by performing safeguards against hypoglycemia of the user prior to any change in basal insulin dosage based on the plurality of data.
  • Non-Invasive Method And System For Measuring Myocardial Ischemia, Stenosis Identification, Localization And Fractional Flow Reserve Estimation

    view source
  • US Patent:
    20210369170, Dec 2, 2021
  • Filed:
    Aug 16, 2021
  • Appl. No.:
    17/402743
  • Inventors:
    - Toronto, CA
    Shyamlal Ramchandani - Kingston, CA
    Timothy William Fawcett Burton - Toronto, CA
    William Sanders - Bethseda MD, US
    Ian Shadforth - Morrisville NC, US
  • International Classification:
    A61B 5/316
    A61B 5/00
    A61B 5/02
    A61B 5/282
    A61B 5/026
  • Abstract:
    The present disclosure facilitates the evaluation of wide-band phase gradient information of the heart tissue to assess, e.g., the presence of heart ischemic heart disease. Notably, the present disclosure provides an improved and efficient method to identify and risk stratify coronary stenosis of the heart using a high resolution and wide-band cardiac gradient obtained from the patient. The patient data are derived from the cardiac gradient waveforms across one or more leads, in some embodiments, resulting in high-dimensional data and long cardiac gradient records that exhibit complex nonlinear variability. Space-time analysis, via numeric wavelet operators, is used to study the morphology of the cardiac gradient data as a phase space dataset by extracting dynamical and geometrical properties from the phase space dataset.
  • Methods And Systems To Configure And Use Neural Networks In Characterizing Physiological Systems

    view source
  • US Patent:
    20200205745, Jul 2, 2020
  • Filed:
    Dec 23, 2019
  • Appl. No.:
    16/725430
  • Inventors:
    - Toronto, CA
    Timothy William Fawcett Burton - Toronto, CA
    Horace Gillins - Toronto, CA
    Shyamlal Ramchandani - Kingston, CA
    William Sanders - Bethesda MD, US
    Ian Shadforth - Morrisville NC, US
  • International Classification:
    A61B 5/00
    G06N 3/08
    G06N 20/00
    G06K 9/62
  • Abstract:
    The exemplified methods and systems facilitate the configuration and training of a neural network (e.g., a deep neural network, a convolutional neural network (CNN), etc.), or ensemble(s) thereof, with a biophysical signal data set to ascertain estimate for the presence or non-presence of disease or pathology in a subject as well as to assess and/or classify disease or pathology, including for example in some cases the severity of such disease or pathology, in a subject. In the context of the heart, the methods and systems described herein facilitate the configuration and training of a neural network, or ensemble(s) thereof, with a cardiac signal data set to ascertain estimate for the presence or non-presence of coronary artery disease or coronary pathology.
  • Non-Invasive Method And System For Measuring Myocardial Ischemia, Stenosis Identification, Localization And Fractional Flow Reserve Estimation

    view source
  • US Patent:
    20200054232, Feb 20, 2020
  • Filed:
    Jul 29, 2019
  • Appl. No.:
    16/524475
  • Inventors:
    - Toronto, CA
    Shyamlal Ramchandani - Kingston, CA
    Timothy William Fawcett Burton - Toronto, CA
    William Sanders - Bethseda MD, US
    Ian Shadforth - Morrisville NC, US
  • International Classification:
    A61B 5/04
    A61B 5/0408
    A61B 5/026
    A61B 5/02
    A61B 5/00
  • Abstract:
    The present disclosure facilitates the evaluation of wide-band phase gradient information of the heart tissue to assess, e.g., the presence of heart ischemic heart disease. Notably, the present disclosure provides an improved and efficient method to identify and risk stratify coronary stenosis of the heart using a high resolution and wide-band cardiac gradient obtained from the patient. The patient data are derived from the cardiac gradient waveforms across one or more leads, in some embodiments, resulting in high-dimensional data and long cardiac gradient records that exhibit complex nonlinear variability. Space-time analysis, via numeric wavelet operators, is used to study the morphology of the cardiac gradient data as a phase space dataset by extracting dynamical and geometrical properties from the phase space dataset.
  • Method And System To Assess Pulmonary Hypertension Using Phase Space Tomography And Machine Learning

    view source
  • US Patent:
    20190365265, Dec 5, 2019
  • Filed:
    Jun 3, 2019
  • Appl. No.:
    16/429593
  • Inventors:
    - Toronto, CA
    Meng Lei - North York, CA
    Ian Shadforth - Morrisville NC, US
    Sunny Gupta - East York, CA
    Timothy Burton - Toronto, US
    Shyamlal Ramchandani - Kingston, CA
  • International Classification:
    A61B 5/046
    A61B 5/00
    A61B 5/04
    G06N 3/08
    A61B 5/044
  • Abstract:
    Phase space tomography methods and systems to facilitate the analysis and evaluation of complex, quasi-periodic system by generating computed phase-space tomographic images and mathematical features as a representation of the dynamics of the quasi-periodic cardiac systems. The computed phase-space tomographic images can be presented to a physician to assist in the assessment of presence or non-presence of disease. In some implementations, the phase space tomographic images are used as input to a trained neural network classifier configured to assess for presence or non-presence of pulmonary hypertension, including pulmonary arterial hypertension.
  • Method And System To Assess Disease Using Phase Space Tomography And Machine Learning

    view source
  • US Patent:
    20190200893, Jul 4, 2019
  • Filed:
    Dec 26, 2018
  • Appl. No.:
    16/232586
  • Inventors:
    - Toronto, CA
    Meng Lei - North York, CA
    Ian Shadforth - Morrisville NC, US
    Sunny Gupta - Belleville, CA
    Timothy William Fawcett Burton - Toronto, CA
    Shyamial Ramchandani - Kingston, CA
  • International Classification:
    A61B 5/053
    A61B 5/04
    A61B 5/00
    A61B 5/044
    G06T 11/00
    G06T 17/20
    G06T 3/40
    G06T 11/60
    A61B 5/026
  • Abstract:
    The exemplified intrinsic phase space tomography methods and systems facilitate the analysis and evaluation of complex, quasi-periodic system by generating computed phase-space tomographic images as a representation of the dynamics of the quasi-periodic cardiac systems. The computed phase-space tomographic images can be presented to a physician to assist in the assessment of presence or non-presence of disease. In some embodiments, the phase space tomographic images are used as input to a trained neural network classifier configured to assess for presence or non-presence of significant coronary artery disease.
  • Discovering Genomes To Use In Machine Learning Techniques

    view source
  • US Patent:
    20190026431, Jan 24, 2019
  • Filed:
    Jul 18, 2017
  • Appl. No.:
    15/653441
  • Inventors:
    - Kingston, CA
    Timothy Burton - Ottowa, CA
    Ali Khosousi - Toronto, CA
    Abhinav Doomra - North York, CA
    Sunny Gupta - Toronto, CA
    Ian Shadforth - Morrisville NC, US
  • International Classification:
    G06F 19/24
    G01N 33/50
    G06F 17/30
    G06F 19/12
  • Abstract:
    A facility for identifying combinations of feature and machine learning algorithm parameters, where each combination can be combined with one or more machine learning algorithms to train a model, is disclosed. The facility evaluates each genome based on the ability of a model trained using that genome and a machine learning algorithm to produce accurate results when applied to a validation data set by, for example, generating a fitness or validation score for the trained model and the corresponding genome used to train the model. Genomes that produce fitness scores that exceed a fitness threshold are selected for mutation, mutated, and the process is repeated. These trained models can then be applied to new data to generate predictions for the underlying subject matter.

Resumes

Ian Shadforth Photo 1

Non Executive Director

view source
Location:
2051 Hibbard St, Alameda, CA 94501
Industry:
Medical Devices
Work:
Alere (formerly Inverness Medical) since Jun 2010
Director of Integrated Health

Inverness Medical Aug 2009 - Jun 2010
Consultant

LifeScan Jun 2007 - Jun 2009
Project Leader

Cranfield University Sep 2005 - Jun 2007
Enterprise Fellow

GlaxoSmithKline Sep 2001 - Sep 2005
Research engineer
Education:
The University of Dundee 2006 - 2008
MBA, Entrepreneurship
Cranfield University 2001 - 2005
EngD, Bioinformatics
University of Cambridge 1998 - 2001
MA, Natural Sciences
Skills:
Strategic Direction and Planning
Systems Development
Cross Functional Management
Product Development
Informatics
Healthcare
Cross Functional Team Leadership
Strategic Planning
Innovation
Strategy
Medical Devices
Program Management
Start Ups
Mobile Devices
Lifesciences
Enterprise Software
Bioinformatics
Biotechnology
It Strategy
R&D
Leadership
Life Sciences
Research and Development
Awards:
Enterprise Fellowship
Royal Society of Edinburgh and the BBSRC
Emerging Chemometrician
Royal Society of Chemistry

Googleplus

Ian Shadforth Photo 2

Ian Shadforth


Get Report for Ian Paul Shadforth from Cary, NC, age ~46
Control profile